Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 1

Status

Recruiting 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Leukemia, Myeloid, Acute 69Breast Neoplasms 52Carcinoma, Non-Small-Cell Lung 29Neoplasms 27Myelodysplastic Syndromes 27Advanced Solid Tumors 27Advanced Solid Tumor 26Prostatic Neoplasms 24Stomach Neoplasms 19Recurrence 19Multiple Myeloma 19Neoplasm Metastasis 18Carcinoma, Hepatocellular 18Lung Neoplasms 16Ovarian Neoplasms 15Pancreatic Neoplasms 14Uterine Cervical Neoplasms 13Solid Tumor 13Sarcoma 13Melanoma 13Leukemia, Myelomonocytic, Chronic 13Colorectal Neoplasms 12Triple Negative Breast Neoplasms 10Small Cell Lung Carcinoma 10Lymphoma, Large B-Cell, Diffuse 10Esophageal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Myeloproliferative Disorders 8Lymphoma, Non-Hodgkin 8Lymphoma, B-Cell 7

Interventions

Injections 4Granulocyte-Macrophage Colony-Stimulating Factor 2Colony-Stimulating Factors 2nabiximols 1fludarabine 1camrelizumab 1Radiofrequency Ablation 1Interleukin-2 1Immune Checkpoint Inhibitors 1Cyclophosphamide 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumor × Injections × Clear all
NCT07326488 2026-04-13

A Study of MHB009C in Patients With Advanced Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
200 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07192107 2026-04-09

A Study of MHB042C in Patients With Advanced Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
200 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07126665 2025-11-18

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
116 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07045454 2025-07-01

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1 Recruiting
200 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡